Unmet Need


Globally, more than 350 million people of all ages suffer from depression. By the year 2030, depression is predicted to become the number one cause of disability. With traditional pharmaceutical options know to have associated side effects, clinical practitioners are increasingly turning to rTMS as a fast, effective treatment option for MDD.